Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPSTONE-IFV: Corticosteroids for Severe Influenza Pneumonia
NCT07351500Phase 3Not yet recruiting
- Sponsor
- Qingyuan Zhan
- Start
- Jan 2026
- Primary completion
- Nov 2028
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of methylprednisolone injection in influenza, community acquired pneumonia (CAP), sponsored by Qingyuan Zhan. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
methylprednisolone injection
03
Conditions
influenzacommunity acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT07351500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07351500.